Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4191351000168118 | Adrenalift (Astragalus membranaceus extract 32.5 mg + Cordyceps sinensis extract 100 mg + Eleutherococcus senticosus extract 26.67 mg + Ganoderma lucidum extract 35 mg + Panax ginseng extract 32.5 mg + Panax quinquefolius extract 30 mg + Withania somnifera extract 40 mg) tablet, 60 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4191361000168116 | Adrenalift tablet, 60, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Adrenalift tablet, 60, bottle | Is a | Adrenalift tablet, 60 | true | Inferred relationship | Some | ||
| Adrenalift tablet, 60, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Adrenalift tablet, 60, bottle | has TPUU | Adrenalift tablet | true | Inferred relationship | Some | 1 | |
| Adrenalift tablet, 60, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Adrenalift tablet, 60, bottle | has TP | Adrenalift | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR